PRESS RELEASE published on 05/29/2024 at 00:05, 1 year 11 months ago Quebec Precious Metals to Issue Shares in Payment of Debts and Deferred Share Units Quebec Precious Metals Corporation announces Debt Settlement and issuance of deferred stock units to CEO, aiming to preserve cash position and compensate executives. Details on related party transaction under MI 61-101 TSX Venture Exchange Debt Settlement Quebec Precious Metals Corporation MI 61-101 Deferred Stock Units
PRESS RELEASE published on 05/28/2024 at 23:20, 1 year 11 months ago Bird River Resources Announces Changes in Its Board of Directors Bird River Resources Inc. announces the resignation of Mr. Warren Hawkins and the appointment of Mr. Vic Moschitto as director. Mr. Moschitto brings extensive experience in finance and marketing Resignation Appointment Finance Marketing Bird River Resources Inc.
PRESS RELEASE published on 05/28/2024 at 23:00, 1 year 11 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
PRESS RELEASE published on 05/28/2024 at 22:31, 1 year 11 months ago Redishred Capital Corp. (“Redishred”, Or The “Company”) Announces Q1 2024 Results Redishred Capital Corp. announces Q1 2024 earnings call results. Revenue and EBITDA show growth, acquisitions enhance Midwest footprint, community events support cancer research Revenue Growth Acquisitions Earnings Call Q1 2024 Redishred Capital Corp.
PRESS RELEASE published on 05/28/2024 at 22:30, 1 year 11 months ago Volatus Releases Q1 2024 Financial Results and Provides General Corporate Update Volatus Aerospace Corp. reports a 39% increase in Services Revenue and a Gross Margin improvement to 34% for Q1 2024, driven by strategic operational efficiencies and product mix optimization Financial Results Volatus Aerospace Corp. Gross Margin Services Revenue Operational Accomplishments
PRESS RELEASE published on 05/28/2024 at 22:30, 1 year 11 months ago Wilmington Eye Now Offering iDose(R) TR as a New Treatment Option to Reduce Eye Pressure in Patients With Ocular Hypertension and Open-Angle Glaucoma Wilmington Eye introduces iDose TR for long-term control of elevated eye pressure in glaucoma patients. iDose TR is an FDA approved treatment providing continuous drug therapy inside the eye FDA Approved Wilmington Eye IDose TR Glaucoma Treatment Eye Pressure Control
PRESS RELEASE published on 05/28/2024 at 22:15, 1 year 11 months ago REFINANCING OF CREDIT FACILITIES AND VOLUNTARY EARLY REPAYMENTS OF AROUND USD 50 MILLION OPTIMIZE FINANCING CONDITIONS AND FURTHER DRIVE BALANCE SHEET DELEVERAGING Birkenstock Holding plc refinances credit facilities and repays USD 50 million early to optimize financing conditions and further deleverage balance sheet Refinancing Balance Sheet Deleveraging Credit Facilities Birkenstock Holding Plc
PRESS RELEASE published on 05/28/2024 at 22:15, 1 year 11 months ago NANOBIOTIX annonce une présentation de nouvelles données et du programme d’immunothérapie de Phase 1 lors de la réunion annuelle 2024 de l’American Society for Clinical Oncology (ASCO) suivi d’une conférence téléphonique et webcast Nanobiotix annonce la présentation de nouvelles données et du programme d'immunothérapie de phase 1 lors de la réunion annuelle 2024 de l'ASCO, suivi d'une conférence téléphonique et webcast Immunothérapie Cancer ASCO 2024 NANOBIOTIX NBTXR3
PRESS RELEASE published on 05/28/2024 at 22:15, 1 year 11 months ago NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call Nanobiotix to present new data from Phase 1 immunotherapy program at 2024 ASCO meeting followed by investor conference call. Details for the call provided Investor Conference Call Immunotherapy ASCO 2024 NANOBIOTIX Phase 1
PRESS RELEASE published on 05/28/2024 at 22:05, 1 year 11 months ago Benefact4 Unveils New Nonprofit Search and Charity Events Feature to Foster Community Engagement and Support Benefact4 introduces new Charity Search and Events feature, providing nonprofits with a platform to engage volunteer-minded individuals, list events, and inspire support. Early sign-ups enjoy free access and feature articles. App aims to enhance user experience and philanthropic ecosystem Nonprofits Benefact4 Charity Search Events Feature Volunteer Engagement
Published on 05/01/2026 at 15:35, 37 minutes ago LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement
Published on 05/01/2026 at 14:00, 2 hours 12 minutes ago CCL Industries Closing of ALT Technologies Acquisition
Published on 05/01/2026 at 14:00, 2 hours 12 minutes ago Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions
Published on 05/01/2026 at 13:01, 3 hours 11 minutes ago BeMetals Announces Resumption of Trading on TSX Venture Exchange and Effective Date of Share Consolidation
Published on 05/01/2026 at 13:00, 3 hours 12 minutes ago Abasca Resources to Participate in Core Days 2026 and Closes $2.5 Million Private Placement
Published on 04/30/2026 at 21:21, 18 hours 50 minutes ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 20 hours 11 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 20 hours 11 minutes ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 20 hours 56 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 20 hours 56 minutes ago AXA annonce les résultats de son Assemblée Générale